TRC-694

N/A

Report date: 2024/12/18 15:50:30
NME

Base Information

Drug NameTRC-694
Drug Alias NameTRC-694JNJ-64290694
ClassificationSmall molecules
Mechanisms of ActionMitogen-Activated Protein Kinase Kinase Kinase 14 inhibitors
TargetsMitogen-Activated Protein Kinase Kinase Kinase 14
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceuticals IncTracon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A